(DSM IV).: Washington DC: American Psychiatric Association; 56.
1994:515–518.
36. Drose, J. A.; Dennis, M. A.; Thickman, D.: Infection in utero:
U.S. findings in 19 cases. Radiology 178:369–374; 1991. 57.
37. Dunn, A. J.; Chapman, Y.; Antoon, M.: Endotoxin-induced
behavioral changes of mice in the multicompartment chamber
are distinct from those of interleukin-1. Neurosci. Res. Commun. 10:63–69; 1992. 58.
38. Dunn, A. J.; Chuluyan, H. E.: The role of cyclo-oxygenase and
lypoxygenase in the interleukin-1-induced activation of the
HPA axis: Dependence on the route of injection. Life Sci.
51:219–225; 1992.
39. Feleder, C.; Refojo, D.; Jarry, H.; Wuttke, W.; Moguilevsky, J. 59.
A.: Bacterial endotoxin inhibits LHRH secretion following the
increased release of hypothalamic GABA levels. Different 60.
effects on amino acid neurotransmitter release. Neuroimmunomodulation 3:342–351; 1996.
40. Feng, Y. J.; Shalts, E.; Xia, L.; Rivier, J.; Rivier, C.; Vale, W.;
Ferin, M.: An inhibitory effect of interleukin-1 alpha on basal 61.
gonadotropin release in the ovariectomized rhesus monkey:
Reversal by a corticotropin releasing factor antagonist. Endocrinology 128:2077–2082; 1991.
41. Goujon, E.; Parnet, P.; Aubert, A.; Goodall, G.; Dantzer, R.: 62.
Corticosterone regulates behavioral effects of lipopolysaccharide and interleukin-1 beta in mice. Am. J. Physiol. 269:R154–
R159; 1995.
42. Grossman, C. J.: Interactions between the gonadal steroids and 63.
the immune system. Science 227:257–261; 1985.
43. Hart, B. L.: Biological basis of the behavior of sick animals.
Neurosci. Biobehav. Rev. 12:123–137; 1988. 64.
44. Hurwitz, A.; Ricciarelli, E.; Botero, L.; Katz, E.; McAllister, J.
M.; Garcia, J. E.; Luikides, J.; Rohan, R. M.; Adashi, E. Y.: The
human intraovarian interleukin-1 (IL-1) system: Highly com- 65.
partmentalized and hormonally dependent regulation of the
genes encoding IL-1, its receptor, and its receptor antagonist. J.
Clin. Invest. 129:3427–3429; 1991. 66.
45. Johnson, R. T.: Infections during pregnancy. In: Devinsky, O.;
Feldmann, E.; Hainline, B., eds. Neurological complications of
pregnancy. New York: Raven Press; 1994:153–162.
46. Johnson, R. W.; Propes, M. J.; Shavit, Y.: Corticosterone modulates behavioral and metabolic effects of lipopolysaccharide. 67.
Am. J. Physiol. 270:R192–R198; 1996.
47. Kaga, N.; Katsuki, Y.; Obata, M.; Shibutani, Y.: Repeated 68.
administration of low dose lipopolysaccharide induces preterm
delivery in mice: A model for human preterm parturition and
for assessment of the therapeutic ability of drugs against preterm delivery. Am. J. Obstet. Gynecol. 174:754–759; 1996. 69.
48. Kalra, P. S.; Sahu, A.; Kalra, S. P.: Interleukin-1 inhibits the ovarian steroid-induced luteinizing hormone surge and release of
hypothalamic luteinizing hormone-releasing hormone in rats. 70.
Endocrinology 126:2145–2152; 1990.
49. Kent, S.; Bluth'e, R. M.; Kelley, K. W.; Dantzer, R.: Sickness
behavior as a new target of drug development. Trends Pharmacol. Sci. 13:24–28; 1992. 71.
50. Kent, S.; Bret-Dibat, J. L.; Kelley, K. W.; Dantzer, R.: Mechanisms of sickness-induced decreases in food-motivated behavior. Neurosci. Biobehav. Rev. 20:171–175; 1996.
51. Kent, S.; Kelley, K. W.; Dantzer, R.: Effects of lipopolysaccha- 72.
ride on food-motivated behavior in the rat are not blocked by an
interleukin-1 receptor antagonist. Neurosci. Lett. 145:83–86;
1992.
52. Kirch, D. G.: Infection and autoimmunity as etiologic factors in 73.
schizophrenia. Schizophr. Bull. 19:355–370; 1993.
53. Kluger, M. J.: Fever: Role of pyrogens and cryogens. Physiol.
Rev. 71:93–127; 1991.
54. Kokia, E.; Ben-Shlomo, I.; Adashi, E. Y.: The ovarian action of 74.
interleukin-1 is receptor mediated: Reversal by a naturally
occurring interleukin-1 receptor antagonist. Fertil. Steril. 63:176–
181; 1995.
55. Komaki, G.; Arimura, A.; Koves, K.: Effect of intravenous 75.
injection of IL-1β on PGE2 levels in several brain areas as determined by microdialysis. Am. J. Physiol. 262:E246–E251; 1992.
